Campbell & CO Investment Adviser LLC Arbutus Biopharma Corp Transaction History
Campbell & CO Investment Adviser LLC
- $1.26 Billion
- Q3 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 73,285 shares of ABUS stock, worth $334,179. This represents 0.03% of its overall portfolio holdings.
Number of Shares
73,285Holding current value
$334,179% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
187Shares Held
118MCall Options Held
1.57MPut Options Held
618K-
Morgan Stanley New York, NY24.2MShares$110 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$60.8 Million19.26% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$52.7 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY10.4MShares$47.6 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.99MShares$41 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $684M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...